Hydroxychloroquine and risk of cancer in patients with primary Sjögren syndrome: propensity score matched landmark analysis

Hydroxychloroquine inhibits systemic inflammation and autophagy and may thus have antineoplastic effects [1]. We investigated the effect of hydroxychloroquine on cancer risk in patients with primary Sjögren syndrome(pSS). We used the Taiwan National Health Insurance Database to compare cancer incide...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yao-Fan, Chen, Yen-Fu, Chung, Ting-Ting, See, Lai-Chu, Yu, Kuang-Hui, Luo, Shue-Fen, Kuo, Chang-Fu, Lai, Jenn-Haung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655212/
https://www.ncbi.nlm.nih.gov/pubmed/29113317
http://dx.doi.org/10.18632/oncotarget.19057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655212/
https://www.ncbi.nlm.nih.gov/pubmed/29113317
http://dx.doi.org/10.18632/oncotarget.19057

Ejemplares similares